We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > T-cell lymphoma

News List

NICE does not recommend chlormethine gel to treat T-cell lymphoma in draft guidance europeanpharmaceuticalreview
August 07, 2020
NICE has issued draft guidance that does not recommend chlormethine gel for mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL).
Cobomarsen Receives Orphan Drug Designation for T-cell Lymphoma Treatment americanpharmaceuticalreview
July 30, 2020
miRagen Therapeutics announced that the Food & Drug Administration (FDA) has granted orphan drug designation to cobomarsen, for the treatment of T-cell lymphoma.
FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot worldpharmanews
November 20, 2018
The U.S. Food and Drug Administration expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma (PTCL).